Explore more publications!

Press Releases

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Justice Department Finds the Special School District of St. Louis’s Seclusion and Restraint Practices Discriminate Against Students with Disabilities

Justice Department Finds the Special School District of St. Louis’s Seclusion and Restraint Practices Discriminate Against Students with Disabilities

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Basics 2 Breakthroughs: Optimizing Materials for Next-Generation Microelectronics

Basics 2 Breakthroughs: Optimizing Materials for Next-Generation Microelectronics

Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
West of Hudson Transit Study Launches

West of Hudson Transit Study Launches

Saint Louis Students Compete in a Project MFG Additive Manufacturing Competition Held at Saint Louis University
Arc Educates Expands Access to Proven Career-Ready Certificate Programs for Students with Disabilities Nationwide
Demin’s Kitchen Atelier Introduces Exclusive Austrian Eco-Materials to the New York City Luxury Market
14-Year-Old Founder, Evan Yadegari, Sells AI Study App to International Buyer
Polymers Market Size to Reach USD 1,424.98 Billion by 2035 - Exclusive Report by Towards Chemical and Materials
Indie Author Training Relaunches With New Courses Dropping Weekly on Redesigned Platform
Roanoke Dental Assistant School Debuts This Spring, Introducing 12-Week Career Training Program
Bloomington Medical Assistant School to Launch 18-Week Healthcare Training Program This Spring
Quanticore.ai Launches Sovereign Audio & 4K Video Frequency Studio
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One
Daré Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference
Organic Fertilizer Market Set to Surge to USD 15.6 Billion by 2033 on Sustainable Agriculture Boom | Study by Market Minds
Vidac Pharma Reports First Patient Dosed in Phase 2b Study of VDA-1102 for High-Risk Actinic Keratosis

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions